WO2022234736A1 - Produit cosmétique comprenant des vésicules - Google Patents

Produit cosmétique comprenant des vésicules Download PDF

Info

Publication number
WO2022234736A1
WO2022234736A1 PCT/JP2022/013197 JP2022013197W WO2022234736A1 WO 2022234736 A1 WO2022234736 A1 WO 2022234736A1 JP 2022013197 W JP2022013197 W JP 2022013197W WO 2022234736 A1 WO2022234736 A1 WO 2022234736A1
Authority
WO
WIPO (PCT)
Prior art keywords
vesicle
oil
cosmetic
fatty acid
vesicles
Prior art date
Application number
PCT/JP2022/013197
Other languages
English (en)
Japanese (ja)
Inventor
啓 渡辺
陽 張
マチユ バンクトウー
允人 宇山
Original Assignee
株式会社 資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 資生堂 filed Critical 株式会社 資生堂
Priority to CN202280026295.2A priority Critical patent/CN117157052A/zh
Priority to JP2023518634A priority patent/JPWO2022234736A1/ja
Publication of WO2022234736A1 publication Critical patent/WO2022234736A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Definitions

  • the present disclosure relates to vesicle-containing cosmetics.
  • Amphipathic compounds having both hydrophilic and hydrophobic properties include, for example, compounds such as phospholipids that form spherical vesicles consisting of bilayer membranes such as lamellar layers in an aqueous phase. be. Such bilayer vesicles are called liposomes or vesicles, and are used in cosmetics and the like.
  • US Pat. No. 6,200,001 discloses, in a continuous aqueous dispersed phase, (a) a lipid phase comprising at least one amphiphilic lipid, ionic or nonionic, associated with at least one stabilizing agent; and (b) in the form of droplets dispersed in the dispersed aqueous phase, 0.2 to 20% by weight of the total weight of the composition.
  • a cosmetic composition for hair care is disclosed containing at least one natural or synthetic essential oil present in proportions and having a weight ratio of lipid phase to essential oil of 0.3-10.
  • Patent Document 2 describes a vesicle composition to be blended in an external skin preparation or cosmetic for the purpose of improving the penetration of active ingredients into the skin or hair, comprising (A) a polyglycerol fatty acid ester, (B) a polyol, and ( C) A vesicle composition containing water as an essential component and having an average particle size of 30 to 300 nm is disclosed.
  • solubilizing oil As a technology for solubilizing oil, a technology that uses micelles prepared using a surfactant is known. However, since micelles can solubilize a small amount of oil, a technology capable of solubilizing oil at a higher concentration than micelles has been desired.
  • micelles have the advantage that it is easy to obtain transparent cosmetics even if the oil is solubilized. Since vesicles generally have a larger particle size than micelles, vesicles have not been used to obtain transparent cosmetics in which oil is solubilized.
  • the subject of the present disclosure is to provide a vesicle-containing cosmetic that can solubilize oil at a higher concentration than when micelles are used, and preferably has excellent transparency.
  • a vesicle-containing cosmetic comprising The vesicle is formed of at least one polyglycerol fatty acid ester having an OH/C ratio of 0.20 to 0.80, and contains oil in the bilayer membrane of the vesicle, A vesicle-containing cosmetic.
  • a vesicle-containing cosmetic that can solubilize oil at a higher concentration than when micelles are used, and preferably has excellent transparency.
  • the vesicle-containing cosmetic of the present disclosure includes a dispersion medium containing water and vesicles dispersed in the dispersion medium, and the vesicles have an OH/C ratio of 0.20 to 0.80. and contains oil in the bilayer membrane of the vesicle.
  • silicone-based surfactants block-type alkylene oxide derivatives, phospholipids, etc. can be used as amphiphilic substances capable of forming vesicles.
  • silicone-based surfactants block-type alkylene oxide derivatives, phospholipids, etc.
  • amphiphilic substances capable of forming vesicles.
  • none of the vesicles formed with these various amphipathic substances can solubilize oil at high concentrations.
  • not all vesicles formed from these various amphipathic substances are excellent in transparency.
  • the present inventors have found a specific polymer having an OH/C ratio, which is a parameter relating to the balance between hydrophilicity and lipophilicity, in the range of 0.20 to 0.80. It was found that a vesicle capable of solubilizing oil at a high concentration can be obtained by employing a glycerin fatty acid ester. Furthermore, the present inventors have also found that a vesicle-containing cosmetic having excellent transparency can be obtained by employing such a specific polyglycerol fatty acid ester.
  • Vesicles formed from the above-mentioned specific polyglycerol fatty acid ester have excellent packing properties of the bilayer membrane that constitutes them. Since the increase can be suitably reduced or suppressed, it is believed that the oil can be solubilized at a high concentration. In addition, since the vesicles formed from the above-described specific polyglycerol fatty acid ester have a relatively small particle size compared to vesicles formed from other amphipathic substances, it is expected that a vesicle-containing cosmetic with excellent transparency can be obtained. thinking.
  • the cosmetic composition described in Patent Document 1 contains an essential oil together with vesicles. Since the essential oil is added to the endoplasmic reticulum, the essential oil is not solubilized in the bilayer membrane of the endoplasmic reticulum.
  • the dispersion medium (aqueous phase) in the vesicle-containing cosmetic of the present disclosure (sometimes simply referred to as “cosmetics”) contains water.
  • the amount of water to be blended is not particularly limited. Or 80% by mass or more, and 95% by mass or less, 90% by mass or less, 85% by mass or less, 80% by mass or less, 75% by mass or less, 70% by mass or less, 65% by mass or less, 60% by mass % or less, 55 mass % or less, or 50 mass % or less.
  • the water that can be used in the vesicle-containing cosmetics of the present disclosure is not particularly limited, and for example, water used in cosmetics and quasi-drugs can be used.
  • water used in cosmetics and quasi-drugs can be used.
  • deionized water, distilled water, ultrapure water, and tap water can be used.
  • the vesicle-containing cosmetic of the present disclosure contains vesicles as a dispersed phase, and oil is contained in the bilayer membrane of the vesicles.
  • vesicles are contained in cosmetics by, for example, a frozen replica method using a frozen replica transmission electron microscope (TEM, H-7650: manufactured by Hitachi, Ltd.), or a small-angle X-ray scattering measurement device ( SAXSess, manufactured by Anton Paar) and Zetasizer Nano (manufactured by Malvern Panalytical) can be used for confirmation.
  • Vesicles are typically dispersed in the aqueous phase as a dispersion of concentric spherically closed vesicles of lamellar liquid crystals.
  • the size of the layered structure in the lamellar liquid crystals can be measured.
  • the average particle size of the vesicles in the cosmetic can be 200 nm or less, 150 nm or less, 100 nm or less, 80 nm or less, or 60 nm or less. It can be 40 nm or more, or 50 nm or more. Vesicles having such an average particle size can further improve the transparency of cosmetics.
  • the average particle size of vesicles can be measured from a photograph taken by a frozen replica transmission electron microscope (TEM, H-7650: manufactured by Hitachi, Ltd.) using the frozen replica method. Such average particle size is the average value of 10 or more arbitrarily selected vesicles.
  • the vesicles of the present disclosure are formed by at least one polyglycerol fatty acid ester having an OH/C ratio of 0.20-0.80.
  • Polyglycerin fatty acid ester is a sustainable material, and as an incidental effect, it can provide a moist feeling when applied to the skin, and can improve the occlusion effect.
  • the amount of polyglycerol fatty acid ester in the vesicle-containing cosmetic of the present disclosure is based on the total amount of the cosmetic from the viewpoint of vesicle formation, oil solubilization in vesicles, transparency of the vesicle-containing cosmetic, etc. , 0.1% by mass or more, 0.3% by mass or more, or 0.5% by mass or more, and 10% by mass or less, 5.0% by mass or less, or 3.0% by mass or less can do.
  • Polyglycerin fatty acid esters can be prepared by esterifying fatty acids with polyglycerin as shown in the following reaction scheme:
  • the portion derived from fatty acids can be called a fatty acid portion
  • the portion derived from polyglycerin can be called a polyglycerin portion.
  • the fatty acid portion corresponds to the lipophilic portion
  • the polyglycerol portion corresponds to the hydrophilic portion.
  • the OH/C ratio of the polyglycerol fatty acid ester is 0.20 or more, 0.25 or more, 0.30 or more, 0.35 or more, 0.40 or more, 0.45 or more, or 0.50 or more. It is preferably 0.80 or less, 0.75 or less, 0.70 or less, 0.65 or less, or 0.60 or less.
  • a polyglycerol fatty acid ester having such an OH/C ratio can improve the ability to solubilize oil in vesicles, and can provide a vesicle-containing cosmetic with excellent transparency.
  • the "OH/C ratio" in the present disclosure means the ratio of the number of hydroxyl groups in the polyglycerin portion to the number of carbon atoms in the fatty acid portion, and is a parameter relating to the balance between hydrophilicity and lipophilicity.
  • the polyglycerin fatty acid ester preferably has a fatty acid moiety with 12 or more, 13 or more, or 14 or more carbon atoms, from the viewpoint of solubilizing oil content in vesicles, transparency of vesicle-containing cosmetics, and the like. Also, it is preferably 17 or less, 16 or less, or 15 or less.
  • Fatty acids that can be used when preparing polyglycerol fatty acid esters may be saturated fatty acids or unsaturated fatty acids, and may be linear fatty acids or branched fatty acids.
  • Such fatty acids can include, for example, lauric acid, myristic acid, and palmitic acid. Among them, myristic acid and lauric acid are preferred.
  • the polyglycerin portion of the polyglycerin fatty acid ester is preferably a dimer or more, a trimer or more, or a tetramer or more from the viewpoint of the oil solubilization ability in the vesicles, the transparency of the vesicle-containing cosmetic, and the like. Also, it is preferably a 10-mer or less, a 9-mer or less, an octamer or less, a 7-mer or less, or a 6-mer or less.
  • the numerical value of n of the polyglycerol fatty acid ester in the above reaction formula matches, for example, the numerical value of 2 in the dimer.
  • polyglycerol fatty acid esters having an OH/C ratio of 0.20 to 0.80 include polyglyceryl-6 myristate, polyglyceryl-2 laurate, polyglyceryl-4 laurate, polyglyceryl-5 laurate, Polyglyceryl-6 laurate and polyglyceryl-10 palmitate can be mentioned.
  • oil content Since the vesicle of the present disclosure is formed using the above-described specific polyglycerol fatty acid ester, the oil content is higher in the bilayer membrane of the vesicle than, for example, micelles formed using such a polyglycerol fatty acid ester. concentration can be solubilized.
  • the solubilization ability of vesicles can be evaluated by the mass ratio of oil to polyglycerol fatty acid ester.
  • a mass ratio can be, for example, 0.01 or more, 0.03 or more, 0.05 or more, 0.07 or more, or 0.10 or more, and 0.30 or less and 0.27 or less. , 0.25 or less, 0.23 or less, or 0.20 or less.
  • oils for example, volatile and non-volatile oils can be used.
  • An oil component can be used individually or in combination of 2 or more types.
  • volatile is intended to exhibit a volatile content of more than 5% when left at 105°C under atmospheric pressure for 3 hours.
  • the volatile content which is a guideline for volatility, can be 10% or more, 20% or more, 40% or more, 50% or more, 60% or more, 80% or more, or 100%.
  • the boiling point at 1 atmosphere (101.325 kPa) can be used as an indicator of volatility.
  • the boiling point can be 250° C. or lower, 240° C. or lower, or 230° C.
  • non-volatile intends to exhibit a volatile content of 5% or less when left at 105°C for 3 hours.
  • the volatile oil is not particularly limited, and examples include volatile silicone oil and volatile hydrocarbon oil.
  • a volatile oil can be used individually or in combination of 2 or more types.
  • Volatile silicone oils include, for example, volatile acyclic silicone oils and volatile cyclic silicone oils.
  • volatile acyclic silicone oils for example, volatile linear silicone oils and volatile branched silicone oils can be used.
  • Volatile linear silicone oils include, for example, dimethylpolysiloxane with a viscosity of 0.65 cs (sometimes referred to as "dimethicone"), dimethylpolysiloxane with a viscosity of 1 cs, dimethylpolysiloxane with a viscosity of 1.5 cs, and dimethylpolysiloxane with a viscosity of 2 cs. and low-molecular-weight linear dimethylpolysiloxane such as dimethylpolysiloxane.
  • dimethylpolysiloxane having a viscosity of 2 cs is preferable from the viewpoint of the ability to solubilize vesicles and the transparency of vesicle-containing cosmetics.
  • these viscosities are intended to be kinematic viscosities at 25°C.
  • Volatile branched silicone oils include, for example, low-molecular-weight branched siloxanes such as methyltrimethicone, tris(trimethylsilyl)methylsilane, and tetrakis(trimethylsilyl)silane.
  • Volatile cyclic silicone oils include, for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane.
  • Volatile hydrocarbon oils include, for example, heptane, isododecane, isohexadecane, and isodecane. Among these, isohexadecane is preferable from the viewpoint of the ability to solubilize vesicles and the transparency of vesicle-containing cosmetics.
  • oils include oils commonly used in cosmetics, such as liquid oils, solid oils, waxes, hydrocarbon oils other than those mentioned above, silicone oils other than those mentioned above, and polar oils. can be done.
  • some UV absorbers act as oils, especially polar oils. Such ultraviolet absorbers can also be regarded as oils.
  • liquid oils examples include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, and linseed oil. , safflower oil, cottonseed oil, perilla oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, sinagi oil, Japanese pear oil, jojoba oil, germ oil, and triglycerin.
  • solid fats and oils examples include cacao butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, mutton tallow, hydrogenated beef tallow, palm kernel oil, lard, beef bone fat, Japanese wax kernel oil, hydrogenated oil, beef Leg fat, Japanese wax, and hydrogenated castor oil.
  • Waxes include, for example, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, wart wax, whale wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugarcane wax, isopropyl lanolin fatty acid, hexyl laurate, Reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether.
  • hydrocarbon oils examples include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and olefin oligomers.
  • silicone oils examples include linear silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane (diphenylsiloxyphenyltrimethicone), and methylhydrogenpolysiloxane having a viscosity of 6 cs or more.
  • polar oil for example, a polar oil with an IOB of 0.10 or more can be used.
  • a ultraviolet absorber can be used individually or in combination of 2 or more types.
  • the IOB value of the polar oil and UV absorber can be, for example, 0.11 or more, 0.12 or more, or 0.13 or more, and 0.50 or less, 0.45 or less, or 0.40 or less.
  • the IOB value is an abbreviation for Inorganic/Organic Balance (inorganic/organic ratio), which is a value representing the ratio of the inorganic value to the organic value, and is an index indicating the degree of polarity of an organic compound. It becomes.
  • silicone oil is preferable among the above-described oils from the viewpoint of transparency of vesicle-containing cosmetics.
  • the vesicle-containing cosmetic of the present disclosure can appropriately contain various components within a range that does not adversely affect the effects of the present disclosure.
  • various components include additive components that can be usually blended in cosmetics, such as surfactants other than polyglycerin fatty acid esters (eg, anionic surfactants), moisturizing agents, thickeners, water-soluble polymers, oils.
  • Optional components can be blended in the oil phase and/or the water phase, and can be used alone or in combination of two or more.
  • an anionic surfactant can function as a dispersant for vesicles in cosmetics, and can further improve the transparency and long-term stability of vesicle-containing cosmetics.
  • the anionic surfactant is included in the cosmetic, at least a portion of which is in the form of micelles containing such active agent in the aqueous phase.
  • N-acylamino acid salts examples include N-acylmethyltaurate salts.
  • N-acylglutamate such as potassium cocoylglutamate, N-acyl-N-methyl- ⁇ -alanine salt, N-acylsarcosinate salt, sodium N-cocoyltaurate, N-cocoyl-N -sodium methyl taurate, N-lauroyl-N-methyl taurate sodium, N-coconut fatty acid-N-methyl taurate sodium, N-coconut fatty acid-N-methyltaurine triethanolamine, N-palm fatty acid-N-ethyl Taurine triethanolamine, magnesium N-cocoyltaurate, magnesium N-cocoyl-N-methyltaurate, magnesium N-lauroyl-N-taurate, magnesium N-lauroyl-N-methyltaurate, and magnesium N-coconut fatty acid-N-methyl Mention may be made of magnesium taurtaurate, magnesium N-cocoy
  • the amount of the anionic surfactant blended is 0.01% by mass or more, 0.03% by mass or more, and 0.05% by mass with respect to the total amount of the cosmetic. % or more, or 0.07% by mass or more, and 1.0% by mass or less, 0.7% by mass or less, 0.5% by mass or less, or 0.3% by mass or less preferable.
  • alcohol is blended as an optional component, the ability to solubilize oil in vesicles or the transparency of vesicle-containing cosmetics can be further improved.
  • Such alcohols include, for example, lower alcohols, polyhydric alcohols, and higher alcohols. Among them, lower alcohols and/or polyhydric alcohols are preferred. Alcohol can be used individually or in combination of 2 or more types.
  • a monohydric alcohol having an alkyl group having 1 to 5 carbon atoms is preferable, and a monohydric alcohol having an alkyl group having 1 to 3 carbon atoms is more preferable.
  • Specific examples include ethanol, propanol, isopropanol, isobutyl alcohol, and t-butyl alcohol, with ethanol being preferred.
  • a lower alcohol can be used individually or in combination of 2 or more types.
  • polyhydric alcohols examples include ethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol, polyethylene glycol, polypropylene glycol, and polybutylene glycol. Among them, dipropylene glycol is preferred.
  • a polyhydric alcohol can be used individually or in combination of 2 or more types.
  • higher alcohols examples include those having a carbon chain length of 16 or more, and specific examples include lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, and monostearyl.
  • linear or branched higher alcohols such as glycerene ether (bacyl alcohol), 2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol and octyldodecanol;
  • the amount of alcohol blended is 1.0% by mass or more, 3.0% by mass or more, and 5.0% by mass relative to the total amount of the cosmetic. % or more, or 7.0 mass % or more, and preferably 20.0 mass % or less, 17.0 mass % or less, or 15.0 mass % or less.
  • the vesicle-containing cosmetic of the present disclosure can exhibit excellent transparency even though the vesicle solubilizes oil.
  • the transparency of cosmetics can be evaluated, for example, by the L value calculated from a color difference meter such as COLOR-EYE 7000A (manufactured by Gretag Macbeth). It is intended that the closer the L value is to 100, the higher the transparency.
  • Cosmetics of the present disclosure can exhibit an L value of 50 or greater, 55 or greater, 60 or greater, 65 or greater, 70 or greater, 75 or greater, 80 or greater, 85 or greater, or 90 or greater.
  • the upper limit of the L value is not particularly limited, and can be set to 100 or less, for example.
  • the vesicle-containing cosmetic of the present disclosure is not limited to the following method, but can be prepared as follows. Various materials described above can be used in the preparation of cosmetics.
  • the above-described polyglycerol fatty acid ester capable of forming a vesicle bilayer membrane, oil, and optionally an oil-soluble drug are mixed to form a mixed solution.
  • the vesicle-containing cosmetic composition of the present disclosure can be obtained by adding this mixed solution to water optionally containing a water-soluble drug and the like, followed by stirring and mixing.
  • the oil can be solubilized in the bilayer membrane of the vesicle.
  • the dosage form of the vesicle-containing cosmetic of the present disclosure is not particularly limited, and examples thereof include liquid, milky lotion, cream, gel, spray, and mousse.
  • “spray” can include mist type spray, aerosol type spray, and the like.
  • the vesicle-containing cosmetic of the present disclosure can be used, for example, as a cosmetic that is spread and applied to the skin, hair, or the like.
  • the product form of the cosmetics of the present disclosure is not particularly limited, but for example, facial cosmetics such as lotions, beauty essences, milky lotions, and packs; makeup cosmetics such as foundations, lipsticks, and eye shadows; body cosmetics; hair cosmetics such as hair liquids, hair tonics, hair conditioners, shampoos, rinses and hair restorers; and ointments.
  • vesicle-containing cosmetic of the present disclosure will be described in more detail below with reference to examples, but the cosmetic of the present disclosure is not limited to these.
  • the compounding amount is indicated by mass%.
  • Examples 1 to 13 and Comparative Examples 1 to 2>> The formulations shown in Tables 1 and 2 and the vesicle-containing cosmetics obtained by the production methods shown below were subjected to the following evaluations, and the results are shown in Tables 1 and 2.
  • ⁇ Evaluation method> evaluation of vesicles
  • the prepared cosmetic was observed with a frozen replica transmission electron microscope (TEM, H-7650: manufactured by Hitachi, Ltd.) using the frozen replica method to confirm the presence or absence of vesicles.
  • TEM, H-7650 manufactured by Hitachi, Ltd.
  • L value which is an index of transparency
  • Gretag Macbeth For cosmetics that are cloudy and difficult to measure accurately, "20 or less" is indicated in the table.
  • the prepared cosmetic was added to a 50 mL transparent glass bottle (outer diameter 2.5 cm), and the appearance of the cosmetic was visually observed in an atmosphere of 25° C. and evaluated according to the following criteria.
  • a and B ratings can be considered pass and C rating fail:
  • C The cosmetic was cloudy, and the opposite side of the cosmetic could not be seen through the glass bottle.
  • vesicle-containing cosmetics were produced by the following method.
  • the numbers shown below correspond to the numbers on the left indicating the names of the ingredients of the formulations in Tables 1 and 2.
  • Example 1 No. 4 and no. The 10 materials were uniformly mixed to obtain an oil phase part.
  • No. 1, No. 2 and No. 9 materials were uniformly mixed to obtain a water phase part.
  • the oil phase part was added to the water phase part and dispersed uniformly with a dispenser to obtain the vesicle-containing cosmetic of Example 1.
  • Example 2-7 and Comparative Examples 1-2 Vesicle-containing cosmetics of Examples 2 to 7 and Comparative Examples 1 and 2 were obtained in the same manner as in Example 1, except that the formulation was changed to that shown in Table 1.
  • Example 8 No. 2, No. 4 and no. 5 materials were uniformly mixed to obtain an oil phase part.
  • No. 1 was taken as the water phase part.
  • the oil phase part was added to the water phase part and dispersed uniformly with a magnetic stirrer to obtain the vesicle-containing cosmetic of Example 8.
  • Example 9-13 Vesicle-containing cosmetics of Examples 9 to 13 were obtained in the same manner as in Example 8, except that the formulation was changed to that shown in Table 2.
  • the vesicle-containing cosmetic of the present disclosure can solubilize any kind of oil at a high concentration and exhibit good transparency. I was able to confirm that I got it. Among others, it was found that when silicone oil was used as the oil component, more excellent transparency could be exhibited.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention fournit un produit cosmétique comprenant des vésicules qui permet une solubilisation d'une huile en haute concentration en comparaison avec le cas où une micelle est mise en œuvre, et qui de préférence se révèle excellent en termes de transparence.　Le produit cosmétique comprenant des vésicules de l'invention contient un milieu de dispersion contenant une eau, et des vésicules dispersées dans le milieu de dispersion. Ces vésicules sont formées par au moins une sorte d'ester d'acide gras de polyglycéryle de rapport ＯＨ／Ｃ compris entre ０,２０ et ０,８０, et contiennent une huile dans une membrane bicouche de vésicule.
PCT/JP2022/013197 2021-05-06 2022-03-22 Produit cosmétique comprenant des vésicules WO2022234736A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202280026295.2A CN117157052A (zh) 2021-05-06 2022-03-22 含有囊泡的化妆料
JP2023518634A JPWO2022234736A1 (fr) 2021-05-06 2022-03-22

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021078522 2021-05-06
JP2021-078522 2021-05-06

Publications (1)

Publication Number Publication Date
WO2022234736A1 true WO2022234736A1 (fr) 2022-11-10

Family

ID=83932086

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/013197 WO2022234736A1 (fr) 2021-05-06 2022-03-22 Produit cosmétique comprenant des vésicules

Country Status (3)

Country Link
JP (1) JPWO2022234736A1 (fr)
CN (1) CN117157052A (fr)
WO (1) WO2022234736A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015189762A (ja) * 2014-03-30 2015-11-02 小林製薬株式会社 水中油型乳化組成物
JP2016008203A (ja) * 2014-06-25 2016-01-18 ロレアル ナノエマルション若しくはマイクロエマルションの形態の又はラメラ構造を有する組成物
JP2020105130A (ja) * 2018-12-28 2020-07-09 小林製薬株式会社 外用乳化組成物
JP2022026892A (ja) * 2020-07-31 2022-02-10 日光ケミカルズ株式会社 毛髪の染色方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015189762A (ja) * 2014-03-30 2015-11-02 小林製薬株式会社 水中油型乳化組成物
JP2016008203A (ja) * 2014-06-25 2016-01-18 ロレアル ナノエマルション若しくはマイクロエマルションの形態の又はラメラ構造を有する組成物
JP2020105130A (ja) * 2018-12-28 2020-07-09 小林製薬株式会社 外用乳化組成物
JP2022026892A (ja) * 2020-07-31 2022-02-10 日光ケミカルズ株式会社 毛髪の染色方法

Also Published As

Publication number Publication date
CN117157052A (zh) 2023-12-01
JPWO2022234736A1 (fr) 2022-11-10

Similar Documents

Publication Publication Date Title
RU2488378C2 (ru) Косметическое средство в форме масло-в-воде
JP3609834B2 (ja) 皮膚外用剤
JP5047369B2 (ja) Ｏ／ｗ微細エマルション外用剤の製造方法
KR101422276B1 (ko) 수중 유형 유화 조성물
EP2559426B1 (fr) Composition d'émulsion eau dans l'huile
KR20180103143A (ko) 리플상 함유 조성물, α겔 형성용 조성물, 및 이를 이용한 피부 외용 조성물 및 α겔 조성물
JP5720998B2 (ja) 化粧料用基剤及びこれを配合してなる化粧料
WO2012117909A1 (fr) Procédé de fabrication pour une composition d'émulsion d'huile dans l'eau
JP2012067024A (ja) 皮膚外用剤
JP2014101344A (ja) 化粧料
JP5046409B2 (ja) 水中油型乳化日焼け止め化粧料
JP2008100937A (ja) Ｏ／ｗ微細乳化外用剤及びその製造方法
JP6982697B2 (ja) 皮膚化粧料用組成物
JP6133618B2 (ja) 油中水型乳化組成物
JP6418626B2 (ja) 油中水型乳化組成物及び該組成物を用いた油中水型乳化化粧料
JP2010024204A (ja) 皮膚外用剤
JP5189836B2 (ja) 油分含有化粧料組成物
WO2022234736A1 (fr) Produit cosmétique comprenant des vésicules
WO2022234737A1 (fr) Produit cosmétique émulsifié de type huile dans l'eau
JP7496206B2 (ja) 水中油型乳化組成物
JP5178100B2 (ja) 皮膚外用剤
JP2023152863A (ja) 皮膚化粧料用組成物
JP7240144B2 (ja) 水中油型乳化化粧料
KR20130028480A (ko) 비중조절제를 포함하는 화장료 조성물
JP2024076141A (ja) 皮膚化粧料の製造方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22798843

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2023518634

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22798843

Country of ref document: EP

Kind code of ref document: A1